HEADER OXIDOREDUCTASE 26-MAR-12 4EC3 TITLE STRUCTURE OF BERBERINE BRIDGE ENZYME, H174A VARIANT IN COMPLEX WITH TITLE 2 (S)-RETICULINE COMPND MOL_ID: 1; COMPND 2 MOLECULE: RETICULINE OXIDASE; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: BERBERINE BRIDGE-FORMING ENZYME, BBE, COMPND 5 TETRAHYDROPROTOBERBERINE SYNTHASE; COMPND 6 EC: 1.21.3.3; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ESCHSCHOLZIA CALIFORNICA; SOURCE 3 ORGANISM_COMMON: CALIFORNIA POPPY; SOURCE 4 ORGANISM_TAXID: 3467; SOURCE 5 GENE: BBE, BBE1; SOURCE 6 EXPRESSION_SYSTEM: KOMAGATAELLA PASTORIS; SOURCE 7 EXPRESSION_SYSTEM_COMMON: PICHIA PASTORIS; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 4922; SOURCE 9 EXPRESSION_SYSTEM_STRAIN: KM71H; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: PPICZALPHA KEYWDS P-CRESOL METHYL HYDROXYLASE SUPERFAMILY, OXIDOREDUCTASE, FAD, BI- KEYWDS 2 COVALENT FLAVINYLATION EXPDTA X-RAY DIFFRACTION AUTHOR A.WINKLER,P.MACHEROUX,K.GRUBER REVDAT 4 13-SEP-23 4EC3 1 HETSYN REVDAT 3 29-JUL-20 4EC3 1 COMPND REMARK SEQADV HETNAM REVDAT 3 2 1 LINK SITE ATOM REVDAT 2 03-OCT-12 4EC3 1 JRNL REVDAT 1 18-JUL-12 4EC3 0 JRNL AUTH S.WALLNER,A.WINKLER,S.RIEDL,C.DULLY,S.HORVATH,K.GRUBER, JRNL AUTH 2 P.MACHEROUX JRNL TITL CATALYTIC AND STRUCTURAL ROLE OF A CONSERVED ACTIVE SITE JRNL TITL 2 HISTIDINE IN BERBERINE BRIDGE ENZYME. JRNL REF BIOCHEMISTRY V. 51 6139 2012 JRNL REFN ISSN 0006-2960 JRNL PMID 22757961 JRNL DOI 10.1021/BI300411N REMARK 2 REMARK 2 RESOLUTION. 2.65 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE: 1.7.3_928) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.65 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 43.19 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.990 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.3 REMARK 3 NUMBER OF REFLECTIONS : 16226 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.183 REMARK 3 R VALUE (WORKING SET) : 0.180 REMARK 3 FREE R VALUE : 0.235 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.020 REMARK 3 FREE R VALUE TEST SET COUNT : 815 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 43.1953 - 4.8137 0.99 2624 139 0.1639 0.2011 REMARK 3 2 4.8137 - 3.8215 0.99 2588 136 0.1430 0.1972 REMARK 3 3 3.8215 - 3.3387 0.98 2542 134 0.1732 0.2350 REMARK 3 4 3.3387 - 3.0335 0.98 2572 135 0.2079 0.2527 REMARK 3 5 3.0335 - 2.8161 0.98 2519 133 0.2301 0.3106 REMARK 3 6 2.8161 - 2.6501 0.98 2566 138 0.2292 0.2923 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.10 REMARK 3 SHRINKAGE RADIUS : 0.86 REMARK 3 K_SOL : 0.34 REMARK 3 B_SOL : 11.84 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.350 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 22.770 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 30.00 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 4.59730 REMARK 3 B22 (A**2) : 3.61670 REMARK 3 B33 (A**2) : -8.21400 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -1.66500 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.004 4218 REMARK 3 ANGLE : 0.873 5741 REMARK 3 CHIRALITY : 0.053 637 REMARK 3 PLANARITY : 0.004 709 REMARK 3 DIHEDRAL : 17.730 1533 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4EC3 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 02-APR-12. REMARK 100 THE DEPOSITION ID IS D_1000071430. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 21-NOV-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : EMBL/DESY, HAMBURG REMARK 200 BEAMLINE : X11 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.8104 REMARK 200 MONOCHROMATOR : SI (111), HORIZONTALLY FOCUSSING REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 300 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 16229 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.650 REMARK 200 RESOLUTION RANGE LOW (A) : 43.200 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.2 REMARK 200 DATA REDUNDANCY : 3.700 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.12300 REMARK 200 FOR THE DATA SET : 9.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.65 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.75 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.9 REMARK 200 DATA REDUNDANCY IN SHELL : 3.60 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.53100 REMARK 200 FOR SHELL : 2.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: PDB ENTRY 3D2H REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.47 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.48 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2 M MGCL2, 30% (W/V) POLYETHYLENE REMARK 280 GLYCOL 4,000, 0.1 M TRIS/HCL, PH 8.5, VAPOR DIFFUSION, SITTING REMARK 280 DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 49.38150 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 46.47150 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 49.38150 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 46.47150 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLU A 20 REMARK 465 ASN A 521 REMARK 465 PHE A 522 REMARK 465 ASP A 523 REMARK 465 TYR A 524 REMARK 465 LEU A 525 REMARK 465 GLU A 526 REMARK 465 LYS A 527 REMARK 465 THR A 528 REMARK 465 LEU A 529 REMARK 465 GLY A 530 REMARK 465 SER A 531 REMARK 465 ASP A 532 REMARK 465 GLY A 533 REMARK 465 GLY A 534 REMARK 465 GLU A 535 REMARK 465 VAL A 536 REMARK 465 VAL A 537 REMARK 465 ILE A 538 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 ND2 ASN A 38 C2 NAG B 1 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 23 -83.69 -93.02 REMARK 500 LEU A 76 79.52 -118.37 REMARK 500 SER A 101 -73.15 -105.61 REMARK 500 SER A 113 138.63 -170.63 REMARK 500 ALA A 163 -12.58 -161.90 REMARK 500 VAL A 227 -40.97 -130.92 REMARK 500 ASP A 286 93.13 -166.23 REMARK 500 GLU A 287 -109.00 51.29 REMARK 500 PHE A 299 68.16 -68.61 REMARK 500 PHE A 392 -135.32 -102.47 REMARK 500 ARG A 409 -108.74 -120.85 REMARK 500 VAL A 448 -169.73 -105.82 REMARK 500 HIS A 459 50.02 -102.31 REMARK 500 HIS A 459 48.56 -101.36 REMARK 500 LEU A 491 -118.46 55.49 REMARK 500 ASP A 505 74.33 -150.45 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3D2J RELATED DB: PDB REMARK 900 STRUCTURE OF BERBERINE BRIDGE ENZYME FROM ESCHSCHOLZIA CALIFORNICA, REMARK 900 TETRAGONAL CRYSTAL FORM REMARK 900 RELATED ID: 3D2D RELATED DB: PDB REMARK 900 STRUCTURE OF BERBERINE BRIDGE ENZYME IN COMPLEX WITH (S)-RETICULINE REMARK 900 RELATED ID: 3FW7 RELATED DB: PDB REMARK 900 STRUCTURE OF BERBERINE BRIDGE ENZYME, H104A VARIANT REMARK 900 RELATED ID: 3FW8 RELATED DB: PDB REMARK 900 STRUCTURE OF BERBERINE BRIDGE ENZYME, C166A VARIANT DBREF 4EC3 A 24 538 UNP P30986 RETO_ESCCA 24 538 SEQADV 4EC3 GLU A 20 UNP P30986 EXPRESSION TAG SEQADV 4EC3 ALA A 21 UNP P30986 EXPRESSION TAG SEQADV 4EC3 GLU A 22 UNP P30986 EXPRESSION TAG SEQADV 4EC3 ALA A 23 UNP P30986 EXPRESSION TAG SEQADV 4EC3 ALA A 174 UNP P30986 HIS 174 ENGINEERED MUTATION SEQRES 1 A 519 GLU ALA GLU ALA GLY ASN ASP LEU LEU SER CYS LEU THR SEQRES 2 A 519 PHE ASN GLY VAL ARG ASN HIS THR VAL PHE SER ALA ASP SEQRES 3 A 519 SER ASP SER ASP PHE ASN ARG PHE LEU HIS LEU SER ILE SEQRES 4 A 519 GLN ASN PRO LEU PHE GLN ASN SER LEU ILE SER LYS PRO SEQRES 5 A 519 SER ALA ILE ILE LEU PRO GLY SER LYS GLU GLU LEU SER SEQRES 6 A 519 ASN THR ILE ARG CYS ILE ARG LYS GLY SER TRP THR ILE SEQRES 7 A 519 ARG LEU ARG SER GLY GLY HIS SER TYR GLU GLY LEU SER SEQRES 8 A 519 TYR THR SER ASP THR PRO PHE ILE LEU ILE ASP LEU MET SEQRES 9 A 519 ASN LEU ASN ARG VAL SER ILE ASP LEU GLU SER GLU THR SEQRES 10 A 519 ALA TRP VAL GLU SER GLY SER THR LEU GLY GLU LEU TYR SEQRES 11 A 519 TYR ALA ILE THR GLU SER SER SER LYS LEU GLY PHE THR SEQRES 12 A 519 ALA GLY TRP CYS PRO THR VAL GLY THR GLY GLY ALA ILE SEQRES 13 A 519 SER GLY GLY GLY PHE GLY MET MET SER ARG LYS TYR GLY SEQRES 14 A 519 LEU ALA ALA ASP ASN VAL VAL ASP ALA ILE LEU ILE ASP SEQRES 15 A 519 ALA ASN GLY ALA ILE LEU ASP ARG GLN ALA MET GLY GLU SEQRES 16 A 519 ASP VAL PHE TRP ALA ILE ARG GLY GLY GLY GLY GLY VAL SEQRES 17 A 519 TRP GLY ALA ILE TYR ALA TRP LYS ILE LYS LEU LEU PRO SEQRES 18 A 519 VAL PRO GLU LYS VAL THR VAL PHE ARG VAL THR LYS ASN SEQRES 19 A 519 VAL ALA ILE ASP GLU ALA THR SER LEU LEU HIS LYS TRP SEQRES 20 A 519 GLN PHE VAL ALA GLU GLU LEU GLU GLU ASP PHE THR LEU SEQRES 21 A 519 SER VAL LEU GLY GLY ALA ASP GLU LYS GLN VAL TRP LEU SEQRES 22 A 519 THR MET LEU GLY PHE HIS PHE GLY LEU LYS THR VAL ALA SEQRES 23 A 519 LYS SER THR PHE ASP LEU LEU PHE PRO GLU LEU GLY LEU SEQRES 24 A 519 VAL GLU GLU ASP TYR LEU GLU MET SER TRP GLY GLU SER SEQRES 25 A 519 PHE ALA TYR LEU ALA GLY LEU GLU THR VAL SER GLN LEU SEQRES 26 A 519 ASN ASN ARG PHE LEU LYS PHE ASP GLU ARG ALA PHE LYS SEQRES 27 A 519 THR LYS VAL ASP LEU THR LYS GLU PRO LEU PRO SER LYS SEQRES 28 A 519 ALA PHE TYR GLY LEU LEU GLU ARG LEU SER LYS GLU PRO SEQRES 29 A 519 ASN GLY PHE ILE ALA LEU ASN GLY PHE GLY GLY GLN MET SEQRES 30 A 519 SER LYS ILE SER SER ASP PHE THR PRO PHE PRO HIS ARG SEQRES 31 A 519 SER GLY THR ARG LEU MET VAL GLU TYR ILE VAL ALA TRP SEQRES 32 A 519 ASN GLN SER GLU GLN LYS LYS LYS THR GLU PHE LEU ASP SEQRES 33 A 519 TRP LEU GLU LYS VAL TYR GLU PHE MET LYS PRO PHE VAL SEQRES 34 A 519 SER LYS ASN PRO ARG LEU GLY TYR VAL ASN HIS ILE ASP SEQRES 35 A 519 LEU ASP LEU GLY GLY ILE ASP TRP GLY ASN LYS THR VAL SEQRES 36 A 519 VAL ASN ASN ALA ILE GLU ILE SER ARG SER TRP GLY GLU SEQRES 37 A 519 SER TYR PHE LEU SER ASN TYR GLU ARG LEU ILE ARG ALA SEQRES 38 A 519 LYS THR LEU ILE ASP PRO ASN ASN VAL PHE ASN HIS PRO SEQRES 39 A 519 GLN SER ILE PRO PRO MET ALA ASN PHE ASP TYR LEU GLU SEQRES 40 A 519 LYS THR LEU GLY SER ASP GLY GLY GLU VAL VAL ILE MODRES 4EC3 ASN A 38 ASN GLYCOSYLATION SITE MODRES 4EC3 ASN A 471 ASN GLYCOSYLATION SITE HET NAG B 1 14 HET NAG B 2 14 HET BMA B 3 11 HET MAN B 4 11 HET MAN B 5 11 HET MAN B 6 11 HET FAD A 601 53 HET REN A 602 24 HET NAG A 609 14 HET CL A 610 1 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM BMA BETA-D-MANNOPYRANOSE HETNAM MAN ALPHA-D-MANNOPYRANOSE HETNAM FAD FLAVIN-ADENINE DINUCLEOTIDE HETNAM REN (S)-RETICULINE HETNAM CL CHLORIDE ION HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN BMA BETA-D-MANNOSE; D-MANNOSE; MANNOSE HETSYN MAN ALPHA-D-MANNOSE; D-MANNOSE; MANNOSE HETSYN REN (1S)-1-(3-HYDROXY-4-METHOXYBENZYL)-6-METHOXY-2-METHYL- HETSYN 2 REN 1,2,3,4-TETRAHYDROISOQUINOLIN-7-OL FORMUL 2 NAG 3(C8 H15 N O6) FORMUL 2 BMA C6 H12 O6 FORMUL 2 MAN 3(C6 H12 O6) FORMUL 3 FAD C27 H33 N9 O15 P2 FORMUL 4 REN C19 H23 N O4 FORMUL 6 CL CL 1- FORMUL 7 HOH *115(H2 O) HELIX 1 1 ALA A 23 ASN A 34 1 12 HELIX 2 2 SER A 48 SER A 57 1 10 HELIX 3 3 ASN A 60 GLN A 64 5 5 HELIX 4 4 SER A 79 LYS A 92 1 14 HELIX 5 5 THR A 144 SER A 156 1 13 HELIX 6 6 GLY A 170 GLY A 178 1 9 HELIX 7 7 MET A 183 GLY A 188 1 6 HELIX 8 8 ALA A 190 ASP A 192 5 3 HELIX 9 9 ASP A 208 GLY A 213 1 6 HELIX 10 10 GLY A 213 ILE A 220 1 8 HELIX 11 11 ALA A 255 LEU A 273 1 19 HELIX 12 12 LEU A 301 PHE A 313 1 13 HELIX 13 13 PRO A 314 GLY A 317 5 4 HELIX 14 14 VAL A 319 TYR A 323 5 5 HELIX 15 15 SER A 327 GLY A 337 1 11 HELIX 16 16 VAL A 341 ASN A 346 5 6 HELIX 17 17 PRO A 368 GLU A 382 1 15 HELIX 18 18 GLY A 394 ILE A 399 1 6 HELIX 19 19 ASN A 423 LYS A 428 5 6 HELIX 20 20 LYS A 429 LYS A 445 1 17 HELIX 21 21 PRO A 446 VAL A 448 5 3 HELIX 22 22 TYR A 456 ILE A 460 5 5 HELIX 23 23 ASP A 461 GLY A 465 5 5 HELIX 24 24 ASN A 471 ASN A 477 1 7 HELIX 25 25 ASN A 477 LEU A 491 1 15 HELIX 26 26 ASN A 493 ASP A 505 1 13 SHEET 1 A 4 HIS A 39 VAL A 41 0 SHEET 2 A 4 ALA A 73 ILE A 75 -1 O ILE A 74 N THR A 40 SHEET 3 A 4 PHE A 117 ASP A 121 1 O LEU A 119 N ILE A 75 SHEET 4 A 4 THR A 96 ARG A 100 1 N ARG A 100 O ILE A 120 SHEET 1 B 5 VAL A 128 ASP A 131 0 SHEET 2 B 5 THR A 136 GLU A 140 -1 O THR A 136 N ASP A 131 SHEET 3 B 5 ALA A 230 LYS A 237 -1 O TRP A 234 N VAL A 139 SHEET 4 B 5 VAL A 194 ILE A 200 -1 N ILE A 198 O TYR A 232 SHEET 5 B 5 ILE A 206 LEU A 207 -1 O LEU A 207 N LEU A 199 SHEET 1 C 2 LEU A 159 GLY A 160 0 SHEET 2 C 2 LEU A 239 PRO A 240 -1 O LEU A 239 N GLY A 160 SHEET 1 D 7 LEU A 324 MET A 326 0 SHEET 2 D 7 VAL A 245 VAL A 254 -1 N VAL A 245 O MET A 326 SHEET 3 D 7 GLN A 289 HIS A 298 -1 O HIS A 298 N THR A 246 SHEET 4 D 7 PHE A 277 ASP A 286 -1 N SER A 280 O LEU A 295 SHEET 5 D 7 GLY A 385 GLY A 391 -1 O LEU A 389 N VAL A 281 SHEET 6 D 7 LEU A 414 TRP A 422 -1 O ILE A 419 N PHE A 386 SHEET 7 D 7 ALA A 355 LEU A 362 -1 N LYS A 359 O TYR A 418 SSBOND 1 CYS A 30 CYS A 89 1555 1555 2.03 LINK ND2 ASN A 38 C1 NAG B 1 1555 1555 1.44 LINK ND1 HIS A 104 C8M FAD A 601 1555 1555 1.47 LINK SG CYS A 166 C6 FAD A 601 1555 1555 1.76 LINK ND2 ASN A 471 C1 NAG A 609 1555 1555 1.44 LINK O4 NAG B 1 C1 NAG B 2 1555 1555 1.44 LINK O4 NAG B 2 C1 BMA B 3 1555 1555 1.44 LINK O3 BMA B 3 C1 MAN B 4 1555 1555 1.44 LINK O2 MAN B 4 C1 MAN B 5 1555 1555 1.44 LINK O2 MAN B 5 C1 MAN B 6 1555 1555 1.44 CISPEP 1 ASN A 451 PRO A 452 0 -1.87 CRYST1 98.763 92.943 63.579 90.00 100.31 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010125 0.000000 0.001841 0.00000 SCALE2 0.000000 0.010759 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015986 0.00000